$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| US FDA APPROVES ONCE-DAILY XIGDUO? XR TABLETS | 30 Oct 2014 |
| OLAPARIB RECEIVES POSITIVE CHMP OPINION | 24 Oct 2014 |
| DIRECTOR/PDMR SHAREHOLDING | 02 Oct 2014 |
| TOTAL VOTING RIGHTS | 01 Oct 2014 |
| ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ESMO | 29 Sep 2014 |
| POSITIVE CHMP OPINION FOR MOVENTIG (NALOXEGOL) | 26 Sep 2014 |
| FDA APPROVES MOVANTIK (NALOXEGOL) TABLETS | 16 Sep 2014 |
| AZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR | 16 Sep 2014 |
| DIRECTOR/PDMR SHAREHOLDING | 10 Sep 2014 |
| TOTAL VOTING RIGHTS | 02 Sep 2014 |
| US DOJ CLOSES INVESTIGATION INTO PLATO | 19 Aug 2014 |
| CAZ-AVI PHASE III RESULTS | 19 Aug 2014 |
| TRALOKINUMAB PHASE III START IN SEVERE ASTHMA | 14 Aug 2014 |
| PHASE III RESULTS LESINURAD COMBINATION THERAPY | 13 Aug 2014 |
| DIRECTOR/PDMR SHAREHOLDING | 04 Aug 2014 |
| TOTAL VOTING RIGHTS | 01 Aug 2014 |
| DIRECTOR/PDMR SHAREHOLDING | 01 Aug 2014 |
| ASTRAZENECA PIPELINE | 31 Jul 2014 |
| SECOND QUARTER & HALF YEAR RESULTS 2014 | 31 Jul 2014 |
| STRATEGIC RESPIRATORY TRANSACTION WITH ALMIRALL | 30 Jul 2014 |
